Fetal bovine serum (FBS) is serum derived from fetal bovine blood that possesses growth inducing and attachment factors essential for the growth of various animal cells, tissues, and microorganisms in culture media. FBS is the most widely used biological supplement in medical research including cell culture media, diagnostics, biopharmaceuticals production, and therapeutics.
The fetal bovine serum market is estimated to be valued at USD 1.86 Bn in 2024 and is expected to reach USD 4.54 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 13.6% from 2024 to 2031.
The global Fetal Bovine Serum Market Demand is experiencing rising demand due to increasing R&D investments in the development of biopharmaceuticals and stem cell therapy. Moreover, the significant growth in diagnostics applications, especially immunodiagnostics, is anticipated to propel over the forecast period.
Get More Insights - Fetal Bovine Serum Market
